Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry.
Adolescent
Adult
Black or African American
/ genetics
Aged
Anthracyclines
/ adverse effects
Antibiotics, Antineoplastic
/ adverse effects
Cancer Survivors
Cardiomyopathies
/ chemically induced
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Infant
Infant, Newborn
Male
Middle Aged
Neoplasms
/ drug therapy
Polymorphism, Single Nucleotide
Prospective Studies
Retrospective Studies
Whole Genome Sequencing
Young Adult
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
01 05 2021
01 05 2021
Historique:
received:
07
08
2020
revised:
19
10
2020
accepted:
02
12
2020
pubmed:
9
12
2020
medline:
18
9
2021
entrez:
8
12
2020
Statut:
ppublish
Résumé
Cardiomyopathy occurs at significantly higher rates in survivors of childhood cancer than the general population, but few studies have evaluated racial or ethnic disparities, and none have assessed potential genetic factors contributing to this outcome. In this study, childhood cancer survivors of African ancestry exposed to cardiotoxic therapies (anthracyclines and/or heart radiotherapy;
Identifiants
pubmed: 33288658
pii: 0008-5472.CAN-20-2675
doi: 10.1158/0008-5472.CAN-20-2675
pmc: PMC8137513
mid: NIHMS1653945
doi:
Substances chimiques
Anthracyclines
0
Antibiotics, Antineoplastic
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2556-2565Subventions
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216354
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA195547
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
©2020 American Association for Cancer Research.
Références
J Cancer Surviv. 2018 Jun;12(3):388-397
pubmed: 29427203
Science. 2012 Jul 6;337(6090):100-4
pubmed: 22604722
J Clin Oncol. 2015 Nov 10;33(32):3774-80
pubmed: 26304888
J Clin Oncol. 2013 Oct 10;31(29):3673-80
pubmed: 24002505
Am J Hum Genet. 2020 Oct 1;107(4):636-653
pubmed: 32946765
J Clin Oncol. 2012 May 1;30(13):1415-21
pubmed: 22124095
Clin Cancer Res. 2019 Nov 15;25(22):6700-6708
pubmed: 31462438
Eur Heart J. 2011 May;32(9):1065-76
pubmed: 21459883
Cancer. 2016 Aug 1;122(15):2426-39
pubmed: 27253866
JAMA Cardiol. 2018 Oct 1;3(10):929-938
pubmed: 30140897
Nat Genet. 2015 Sep;47(9):1079-84
pubmed: 26237429
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Circulation. 2019 Sep 17;140(12):1041-1043
pubmed: 31446776
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
Pediatr Blood Cancer. 2011 May;56(5):825-36
pubmed: 21370418
Ann Intern Med. 2016 Jan 19;164(2):93-101
pubmed: 26747086
BMJ. 2009 Dec 08;339:b4606
pubmed: 19996459
J Pers Med. 2018 Feb 26;8(1):
pubmed: 29495422
J Card Fail. 2000 Sep;6(3):183-6
pubmed: 10997742
Eur Heart J. 2014 Apr;35(16):1069-77
pubmed: 23853074
Nat Rev Genet. 2013 Jul;14(7):460-70
pubmed: 23752795
J Clin Oncol. 2014 Mar 1;32(7):647-53
pubmed: 24470002
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Circulation. 2019 Jul 2;140(1):31-41
pubmed: 30987448
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
J Clin Oncol. 2016 May 10;34(14):1634-43
pubmed: 27001569
Am J Cardiol. 2008 Apr 1;101(7):1016-22
pubmed: 18359324
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):666-674
pubmed: 28035022
J Clin Oncol. 2018 Jul 10;36(20):2078-2087
pubmed: 29847298
J Adolesc Young Adult Oncol. 2017 Sep;6(3):414-421
pubmed: 28530506
PLoS One. 2017 Mar 15;12(3):e0172995
pubmed: 28296976
Pediatr Blood Cancer. 2018 Sep;65(9):e27228
pubmed: 29797644
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
Cancer Res. 2020 Sep 1;80(17):3755-3764
pubmed: 32554749
J Clin Oncol. 2016 Mar 10;34(8):863-70
pubmed: 26811534